REGENXBIO Inc. rose 10.1% on Wednesday, November 11, 2026, on 1,845,200 shares. No headline about RGNX came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
REGENXBIO Inc. (RGNX:NASDAQ) closed at $7.64 on November 13, 2026, down 4.86% on the day. The stock trades 52.8% below its 52-week high of $16.19 and 40.1% above its 52-week low of $5.46. Over the past year, it lost 33.6%. REGENXBIO Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since November 13, 2025, RGNX closed higher on 128 days (51%). Its best day was March 9, 2026 (+20.00%) and its worst was May 14, 2026 (-37.80%). The stock moved 10% or more in a single session 17 times. It opened at least 5% above the previous day's high 2 times.
Regenxbio Inc is a biotechnology company. It is engaged in the development, commercialization and licensing of recombinant adeno-associated virus gene therapy.
Find more stocks like RGNX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.